In this issue of Developmental Cell, Lueuroond et al. developed a tracing system, using the uncharacterized early epithelial-mesenchymal transition (EMT)-marker Tenascin C, to monitor cells undergoing partial EMT during malignant mammary cancer progression. They find that partial, but not full, EMT contributes to metastasis and that full EMT contributes to chemoresistance
EMT (epithelial-mesenchymal transition) is a morphogenetic process in which cells loose their epithe...
In cancer, the epithelial-to-mesenchymal transition (EMT) is associated with tumour stemness, metast...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
Epithelial-mesenchymal transition (EMT) is a transient, reversible process of cell de-differentiatio...
Although major progress has been achieved in treating breast cancer patients, metastatic breast canc...
Activation of epithelial-mesenchymal transition (EMT) is important for cancer cell dissemination. Tw...
AbstractAlthough major progress has been achieved in treating breast cancer patients, metastatic bre...
Breast cancer is a leading cause of mortality in women worldwide. The lethality associated with the ...
Metastases are responsible for the majority of breast cancer�associated deaths. The contribution o...
Epithelial to mesenchymal transition (EMT) is a process involved in embryonic development, but it al...
In this issue of Developmental Cell, Li et al. develop a novel lineage tracing system to record EMT ...
The epithelial to mesenchymal transition (EMT) is a cellular program that is involved in embryonic d...
AbstractTwo recent studies provide intriguing evidence that challenges the role of the epithelial–me...
Epithelial cancers make up the vast majority of cancer types and, during the transition from benign ...
AbstractEpithelial-mesenchymal transitions (EMT) are vital for morphogenesis during embryonic develo...
EMT (epithelial-mesenchymal transition) is a morphogenetic process in which cells loose their epithe...
In cancer, the epithelial-to-mesenchymal transition (EMT) is associated with tumour stemness, metast...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
Epithelial-mesenchymal transition (EMT) is a transient, reversible process of cell de-differentiatio...
Although major progress has been achieved in treating breast cancer patients, metastatic breast canc...
Activation of epithelial-mesenchymal transition (EMT) is important for cancer cell dissemination. Tw...
AbstractAlthough major progress has been achieved in treating breast cancer patients, metastatic bre...
Breast cancer is a leading cause of mortality in women worldwide. The lethality associated with the ...
Metastases are responsible for the majority of breast cancer�associated deaths. The contribution o...
Epithelial to mesenchymal transition (EMT) is a process involved in embryonic development, but it al...
In this issue of Developmental Cell, Li et al. develop a novel lineage tracing system to record EMT ...
The epithelial to mesenchymal transition (EMT) is a cellular program that is involved in embryonic d...
AbstractTwo recent studies provide intriguing evidence that challenges the role of the epithelial–me...
Epithelial cancers make up the vast majority of cancer types and, during the transition from benign ...
AbstractEpithelial-mesenchymal transitions (EMT) are vital for morphogenesis during embryonic develo...
EMT (epithelial-mesenchymal transition) is a morphogenetic process in which cells loose their epithe...
In cancer, the epithelial-to-mesenchymal transition (EMT) is associated with tumour stemness, metast...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
DOI
Add to ORKG